Table 1.
Multipotential drug | Targeted secondary injury mechanism | Reference |
---|---|---|
Statins | Excitotoxicity | [28] |
Apoptosis | [30, 32] | |
Inflammation | [27, 35, 36] | |
Edema | [27, 35] | |
BBB disruption | [35] | |
Progesterone | Excitotoxicity | [46] |
Apoptosis | [47–49] | |
Oxidative stress | [50] | |
Inflammation | [52, 53] | |
Edema | [49, 54] | |
Cyclosporine A | Mitochondrial dysfunction | [64, 66, 70, 71] |
Calpain activation | [67, 71] | |
Apoptosis | [64] | |
Oxidative stress | [71, 72] | |
Diketopiperazine | Apoptosis | [76, 77, 80] |
Calpain and cathepsin activation | [76, 79] | |
Inflammation | [80] | |
Cell cycle inhibitors | Apoptosis | [88–91] |
Inflammation | [87, 88, 91] | |
PARP inhibitors | Apoptosis | [103] |
Inflammation | [104–106] |